Results 171 to 180 of about 23,442,365 (336)

Embeddedness of Regions in European Knowledge Networks: A Comparative Analysis of Inter-Regional R&D Collaborations, Co-Patents and Co-Publications

, 2013
Iris Wanzenböck, Thomas Scherngell, Thomas Brenner   +2 more
openalex   +1 more source

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham, Jasibel Vasquez‐Gonzalez, Samantha M. Barnada, Salome Tchotorlishvili, Latese Jones, Ryan Maguire, Genevieve Lewis, Kinza Rizwan, Jenny Deng, Salma Koachar, Drithi Patel, Hailey Shankle, Tessa Mulders, Namra Ajmal, Charalambos Solomides, Emad S. Alnemri, Teresa F. Alnemri, Ayesha A. Shafi, Leonard G. Gomella, Wm Kevin Kelly, Steven B. McMahon, Matthew J. Schiewer   +21 more
wiley   +1 more source

Revealing Chemical Trends: Insights from Data-Driven Visualization and Patent Analysis in Exposomics Research. [PDF]

Environ Sci Technol Lett
Aurich D, Schymanski EL, de Jesus Matias F, Thiessen PA, Pang J.   +4 more
europepmc   +1 more source

LiDAR Innovations: Insights from a Patent and Scientometric Analysis

Raj Bridgelall
openalex   +2 more sources

Application of Enterprise Risk Management (ERM) Principles to Patent Freedom to Operate (FTO) Analysis: A Novel 'IP-RM' System [PDF]

, 2016
Gillian Fenton
openalex  

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

Molecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan, Irina Primac, Emre Etlioglu, Laurens Debruyne, Ann Janssen, Magy Sallam, Kevin Tabury, Roel Quintens, Wiebren Tjalma, Mohammed Abderrafi Benotmane   +9 more
wiley   +1 more source

Guided Design of Efficient Oxygen Evolution Catalysts Using Patent Analysis. [PDF]

ACS Omega
Zhang W, Zhao Y, Xu J, Jia B, Zhang W, Qin M.   +5 more
europepmc   +1 more source

Identifying the Knowledge Networks in Mobile Ecosystem Based on Patent Citation Analysis [PDF]

, 2015
Sanghoon Lee, Wonjoon Kim, Hakyeon Lee, Jeonghwan Jeon   +3 more
openalex  

Percutaneous transluminal balloon angioplasty in stenosis of native hemodialysis arteriovenous fistulas: technical success and analysis of factors affecting postprocedural fistula patency

, 2015
Ayşe Aktaş, Alper Bozkurt, Bülent Aktaş, İsmail Kırbaş   +3 more
openalex   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source